In contrast to heparin, enoxaparin:
Enoxaprin is a LMW heparin. It does not require monitoring. Both heparin as well as enoxaprin do not cross placenta and are not teratogenic.
Can be used without monitoring the patient's aPTT
Is less likely to have a teratogenic effect
Is more likely to be given intravenously
Is more likely to cause thrombosis and thrombocytopenia
Hematology